Accessibility Statement

Accessibility Statement for the website for Private Entities referred to in Article 3, paragraph 1-bis of Law no. 4 of January 9, 2004

Laboratorio Italiano Biochimico Farmaceutico Lisapharma Spa is committed to making its website accessible in accordance with Law no. 4 of January 9, 2004. This accessibility statement applies to: https://lisapharma.it

Compliance Status

Partially compliant

This website is partially compliant with the requirements set out in Appendix A of the UNI CEI EN 301549 standard due to the non-compliance cases listed below.

Non-accessible content

The following content is not accessible for the following reasons:

a) Non-compliance with Law no. 4 of January 9, 2004:
• 9.1.1.1 – Some non-text content presented to users lacks a text alternative that serves the same purpose;
• 9.1.3.1 – In some cases, the information, structure, or relationships conveyed by the presentation of pages cannot be programmatically determined (or are not available through text);
• 9.1.3.5 – In some forms, fields collecting personal information (such as name, address, email, etc.) do not programmatically expose the intended purpose;
• 9.1.4.1 – In some instances, color is used as the sole means of conveying information, indicating an action, or distinguishing an element;
• 9.1.4.3 – In some cases, text or images containing text do not meet the minimum contrast ratio requirements, except in situations exempt from these criteria, such as logos or purely decorative content;
• 9.1.4.11 – For some essential user interface components, including their active or selected states, the visual contrast against adjacent colors is below the required 3:1 ratio;
• 9.2.1.1 – Some functionalities are not accessible via keyboard or equivalent interfaces;
• 9.2.4.4 - In some cases, the link text alone or in conjunction with its surrounding context does not clearly convey its purpose;
• 9.2.4.7 – On some interactive elements, the focus indicator is not visible;
• 9.4.1.1 – The markup code of some web pages does not fully comply with the language specifications, including syntax errors, duplicate attributes, or non-unique IDs;
• 9.4.1.3 – In some cases, status messages are not programmed to be detected by assistive technologies without requiring focus changes;
 

Drafting of the Accessibility Statement

This statement was drafted on: December 9, 2025
The declaration was based on:
• An assessment carried out by third parties

Contact and Feedback Mechanism

To report issues, write to the following email address:: info@lisapharma.it

Reporting to AgID

In case of unsatisfactory response or no response within thirty days, a report may be submitted through the following link: https://www.agid.gov.it/it

Website Information

1. Website publication date: December 30, 2022
2. Usability tests conducted: no
3. CMS used: CMS NW

Organization Information

1. Number of employees with disabilities in the organization: 2 2. Number of workstations for employees with disabilities: none